CN Stock MarketDetailed Quotes

603079 Zhejiang Shengda Bio-Pharm

Watchlist
  • 11.38
  • +0.25+2.25%
Market Closed Jul 17 15:00 CST
1.95BMarket Cap-36242P/E (TTM)

Zhejiang Shengda Bio-Pharm Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
9.19%184.83M
-1.44%727.41M
1.53%544.11M
3.59%363.03M
-8.58%169.28M
-6.55%738.02M
-7.56%535.91M
-10.17%350.44M
-3.52%185.17M
-8.95%789.73M
Operating revenue
9.19%184.83M
-1.44%727.41M
1.53%544.11M
3.59%363.03M
-8.58%169.28M
-6.55%738.02M
-7.56%535.91M
-10.17%350.44M
-3.52%185.17M
-8.95%789.73M
Other operating revenue
----
82.81%1.94M
----
10.67%1.02M
----
-13.42%1.06M
----
41.46%925.62K
----
-82.59%1.23M
Total operating cost
5.56%177.35M
3.00%729.02M
8.15%540.12M
12.91%360.97M
0.48%168.01M
-3.13%707.79M
-4.83%499.43M
-9.14%319.7M
-0.84%167.21M
18.75%730.67M
Operating cost
7.39%147.71M
0.62%610.95M
8.92%448.56M
15.37%300M
2.26%137.55M
8.18%607.17M
0.14%411.83M
-6.28%260.04M
-2.42%134.51M
42.55%561.27M
Operating tax surcharges
50.18%2.25M
9.11%9.41M
19.40%6.83M
23.64%4.16M
-32.00%1.5M
-21.69%8.63M
-9.79%5.72M
-11.95%3.36M
17.75%2.2M
-10.05%11.02M
Operating expense
-7.39%2.77M
7.19%14.2M
-5.55%9.7M
2.54%6.64M
5.73%2.99M
6.24%13.25M
44.44%10.27M
49.17%6.48M
122.79%2.83M
-56.37%12.47M
Administration expense
1.43%17.75M
-1.96%61.96M
-19.88%53.34M
-13.90%35.63M
-1.23%17.5M
-35.11%63.2M
-2.23%66.58M
-0.59%41.39M
-16.61%17.72M
-20.53%97.4M
Financial expense
-42.32%-1.03M
52.31%-10.44M
63.36%-8.5M
41.57%-6.68M
-126.25%-721.61K
-346.76%-21.88M
-688.39%-23.19M
-325.55%-11.43M
247.70%2.75M
-60.54%8.87M
-Interest expense (Financial expense)
279.23%573.62K
-66.28%1.54M
-79.46%948.16K
-85.45%413.68K
-91.28%151.26K
-20.84%4.56M
6.87%4.62M
-7.48%2.84M
52.66%1.73M
46.85%5.76M
-Interest Income (Financial expense)
38.06%-1.27M
-110.92%-8.41M
-41.82%-5.33M
-335.97%-3.52M
-411.12%-2.05M
-35.83%-3.99M
11.65%-3.76M
69.55%-807.53K
74.73%-401.85K
29.94%-2.93M
Research and development
-14.09%7.9M
14.72%42.92M
6.96%30.19M
6.81%21.22M
27.74%9.19M
-5.61%37.42M
0.65%28.22M
1.72%19.86M
-12.68%7.2M
11.09%39.64M
Credit Impairment Loss
-182.25%-856.53K
-592.56%-3.16M
-608.89%-1.12M
-199.50%-1.69M
80.66%-303.46K
49.07%-456.39K
88.71%-158.09K
56.24%-562.81K
-54.76%-1.57M
-334.77%-896.1K
Asset Impairment Loss
---2.71M
-182.91%-50.81M
23.27%-4.83M
-2.53%-5.27M
----
-174.38%-17.96M
17.26%-6.3M
-23.72%-5.14M
92.83%-150.7K
50.66%-6.55M
Other net revenue
-99.43%26.38K
-844.91%-44.06M
-87.43%2.15M
-108.04%-1.2M
-17.25%4.61M
-73.57%5.92M
18.89%17.14M
27.99%14.97M
302.85%5.57M
573.08%22.38M
Fair value change income
----
100.01%100.88
300.18%28.84K
221.61%17.52K
----
-6,325.82%-897.06K
95.82%-14.41K
97.34%-14.41K
---14.41K
--14.41K
Invest income
149.72%1.69M
-96.40%406.51K
-93.12%735.39K
-93.55%677.25K
-69.26%677.25K
-47.58%11.29M
-33.38%10.69M
-9.89%10.5M
2,164.20%2.2M
1,536.85%21.54M
Asset deal income
----
132.20%202.17K
206.32%301.71K
252.88%301.71K
----
6,489.49%87.07K
7,354.35%98.5K
--85.5K
--85.5K
110.16%1.32K
Other revenue
-55.11%1.9M
-32.87%9.3M
-45.08%7.04M
-52.92%4.76M
-15.55%4.24M
67.44%13.85M
65.92%12.82M
67.62%10.11M
13.95%5.02M
20.73%8.27M
Operating profit
27.70%7.51M
-226.35%-45.68M
-88.55%6.14M
-98.14%852.5K
-75.02%5.88M
-55.61%36.15M
-22.68%53.62M
-8.55%45.71M
-4.71%23.53M
-67.07%81.44M
Add:Non operating Income
-85.91%65.9K
213.65%2.99M
-17.66%635.2K
-40.69%300.23K
218.73%467.68K
93.14%953.47K
65.50%771.43K
75.11%506.19K
-40.63%146.73K
74.08%493.67K
Less:Non operating expense
-99.65%2.66K
353.26%2.62M
336.05%1.71M
327.45%1.1M
54,783.87%769.57K
-69.49%578.54K
-84.52%392.99K
322.30%256.96K
-97.66%1.4K
-92.07%1.9M
Total profit
35.75%7.57M
-224.05%-45.31M
-90.63%5.06M
-99.88%54.37K
-76.45%5.58M
-54.37%36.52M
-19.74%54M
-8.47%45.96M
-4.84%23.68M
-64.22%80.04M
Less:Income tax cost
-1.69%2.26M
46.16%8.89M
-15.02%7.69M
-10.27%6.1M
-29.79%2.3M
-25.97%6.09M
19.76%9.05M
48.37%6.8M
16.42%3.28M
-75.61%8.22M
Net profit
62.12%5.3M
SL-54.2M
SL-2.63M
SL-6.05M
-83.96%3.27M
-57.62%30.44M
-24.74%44.95M
-14.18%39.16M
-7.56%20.4M
-62.19%71.82M
Net profit from continuing operation
62.12%5.3M
-278.07%-54.2M
-105.84%-2.63M
-115.45%-6.05M
-83.96%3.27M
-57.62%30.44M
-24.74%44.95M
-14.18%39.16M
-7.56%20.4M
-62.19%71.82M
Less:Minority Profit
779.46%1.49M
86.73%-138.76K
201.45%1.06M
136.72%283.15K
45.72%-219.41K
73.43%-1.05M
75.39%-1.05M
65.87%-771.17K
69.50%-404.2K
47.30%-3.93M
Net profit of parent company owners
9.22%3.81M
-271.71%-54.06M
-108.02%-3.69M
-115.86%-6.33M
-83.22%3.49M
-58.44%31.48M
-28.10%45.99M
-16.62%39.93M
-11.07%20.8M
-61.63%75.76M
Earning per share
Basic earning per share
0.00%0.02
-277.78%-0.32
-107.41%-0.02
-117.39%-0.04
-83.33%0.02
-59.09%0.18
-27.03%0.27
-17.86%0.23
-14.29%0.12
-62.39%0.44
Diluted earning per share
0.00%0.02
-277.78%-0.32
-107.41%-0.02
-117.39%-0.04
-83.33%0.02
-59.09%0.18
-27.03%0.27
-17.86%0.23
-14.29%0.12
-62.39%0.44
Other composite income
Total composite income
62.12%5.3M
-278.07%-54.2M
-105.84%-2.63M
-115.45%-6.05M
-83.96%3.27M
-57.62%30.44M
-24.74%44.95M
-14.18%39.16M
-7.56%20.4M
-62.19%71.82M
Total composite income of parent company owners
9.22%3.81M
-271.71%-54.06M
-108.02%-3.69M
-115.86%-6.33M
-83.22%3.49M
-58.44%31.48M
-28.10%45.99M
-16.62%39.93M
-11.07%20.8M
-61.63%75.76M
Total composite income of minority owners
779.46%1.49M
86.73%-138.76K
201.45%1.06M
136.72%283.15K
45.72%-219.41K
73.43%-1.05M
75.39%-1.05M
65.87%-771.17K
69.50%-404.2K
47.30%-3.93M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 9.19%184.83M-1.44%727.41M1.53%544.11M3.59%363.03M-8.58%169.28M-6.55%738.02M-7.56%535.91M-10.17%350.44M-3.52%185.17M-8.95%789.73M
Operating revenue 9.19%184.83M-1.44%727.41M1.53%544.11M3.59%363.03M-8.58%169.28M-6.55%738.02M-7.56%535.91M-10.17%350.44M-3.52%185.17M-8.95%789.73M
Other operating revenue ----82.81%1.94M----10.67%1.02M-----13.42%1.06M----41.46%925.62K-----82.59%1.23M
Total operating cost 5.56%177.35M3.00%729.02M8.15%540.12M12.91%360.97M0.48%168.01M-3.13%707.79M-4.83%499.43M-9.14%319.7M-0.84%167.21M18.75%730.67M
Operating cost 7.39%147.71M0.62%610.95M8.92%448.56M15.37%300M2.26%137.55M8.18%607.17M0.14%411.83M-6.28%260.04M-2.42%134.51M42.55%561.27M
Operating tax surcharges 50.18%2.25M9.11%9.41M19.40%6.83M23.64%4.16M-32.00%1.5M-21.69%8.63M-9.79%5.72M-11.95%3.36M17.75%2.2M-10.05%11.02M
Operating expense -7.39%2.77M7.19%14.2M-5.55%9.7M2.54%6.64M5.73%2.99M6.24%13.25M44.44%10.27M49.17%6.48M122.79%2.83M-56.37%12.47M
Administration expense 1.43%17.75M-1.96%61.96M-19.88%53.34M-13.90%35.63M-1.23%17.5M-35.11%63.2M-2.23%66.58M-0.59%41.39M-16.61%17.72M-20.53%97.4M
Financial expense -42.32%-1.03M52.31%-10.44M63.36%-8.5M41.57%-6.68M-126.25%-721.61K-346.76%-21.88M-688.39%-23.19M-325.55%-11.43M247.70%2.75M-60.54%8.87M
-Interest expense (Financial expense) 279.23%573.62K-66.28%1.54M-79.46%948.16K-85.45%413.68K-91.28%151.26K-20.84%4.56M6.87%4.62M-7.48%2.84M52.66%1.73M46.85%5.76M
-Interest Income (Financial expense) 38.06%-1.27M-110.92%-8.41M-41.82%-5.33M-335.97%-3.52M-411.12%-2.05M-35.83%-3.99M11.65%-3.76M69.55%-807.53K74.73%-401.85K29.94%-2.93M
Research and development -14.09%7.9M14.72%42.92M6.96%30.19M6.81%21.22M27.74%9.19M-5.61%37.42M0.65%28.22M1.72%19.86M-12.68%7.2M11.09%39.64M
Credit Impairment Loss -182.25%-856.53K-592.56%-3.16M-608.89%-1.12M-199.50%-1.69M80.66%-303.46K49.07%-456.39K88.71%-158.09K56.24%-562.81K-54.76%-1.57M-334.77%-896.1K
Asset Impairment Loss ---2.71M-182.91%-50.81M23.27%-4.83M-2.53%-5.27M-----174.38%-17.96M17.26%-6.3M-23.72%-5.14M92.83%-150.7K50.66%-6.55M
Other net revenue -99.43%26.38K-844.91%-44.06M-87.43%2.15M-108.04%-1.2M-17.25%4.61M-73.57%5.92M18.89%17.14M27.99%14.97M302.85%5.57M573.08%22.38M
Fair value change income ----100.01%100.88300.18%28.84K221.61%17.52K-----6,325.82%-897.06K95.82%-14.41K97.34%-14.41K---14.41K--14.41K
Invest income 149.72%1.69M-96.40%406.51K-93.12%735.39K-93.55%677.25K-69.26%677.25K-47.58%11.29M-33.38%10.69M-9.89%10.5M2,164.20%2.2M1,536.85%21.54M
Asset deal income ----132.20%202.17K206.32%301.71K252.88%301.71K----6,489.49%87.07K7,354.35%98.5K--85.5K--85.5K110.16%1.32K
Other revenue -55.11%1.9M-32.87%9.3M-45.08%7.04M-52.92%4.76M-15.55%4.24M67.44%13.85M65.92%12.82M67.62%10.11M13.95%5.02M20.73%8.27M
Operating profit 27.70%7.51M-226.35%-45.68M-88.55%6.14M-98.14%852.5K-75.02%5.88M-55.61%36.15M-22.68%53.62M-8.55%45.71M-4.71%23.53M-67.07%81.44M
Add:Non operating Income -85.91%65.9K213.65%2.99M-17.66%635.2K-40.69%300.23K218.73%467.68K93.14%953.47K65.50%771.43K75.11%506.19K-40.63%146.73K74.08%493.67K
Less:Non operating expense -99.65%2.66K353.26%2.62M336.05%1.71M327.45%1.1M54,783.87%769.57K-69.49%578.54K-84.52%392.99K322.30%256.96K-97.66%1.4K-92.07%1.9M
Total profit 35.75%7.57M-224.05%-45.31M-90.63%5.06M-99.88%54.37K-76.45%5.58M-54.37%36.52M-19.74%54M-8.47%45.96M-4.84%23.68M-64.22%80.04M
Less:Income tax cost -1.69%2.26M46.16%8.89M-15.02%7.69M-10.27%6.1M-29.79%2.3M-25.97%6.09M19.76%9.05M48.37%6.8M16.42%3.28M-75.61%8.22M
Net profit 62.12%5.3MSL-54.2MSL-2.63MSL-6.05M-83.96%3.27M-57.62%30.44M-24.74%44.95M-14.18%39.16M-7.56%20.4M-62.19%71.82M
Net profit from continuing operation 62.12%5.3M-278.07%-54.2M-105.84%-2.63M-115.45%-6.05M-83.96%3.27M-57.62%30.44M-24.74%44.95M-14.18%39.16M-7.56%20.4M-62.19%71.82M
Less:Minority Profit 779.46%1.49M86.73%-138.76K201.45%1.06M136.72%283.15K45.72%-219.41K73.43%-1.05M75.39%-1.05M65.87%-771.17K69.50%-404.2K47.30%-3.93M
Net profit of parent company owners 9.22%3.81M-271.71%-54.06M-108.02%-3.69M-115.86%-6.33M-83.22%3.49M-58.44%31.48M-28.10%45.99M-16.62%39.93M-11.07%20.8M-61.63%75.76M
Earning per share
Basic earning per share 0.00%0.02-277.78%-0.32-107.41%-0.02-117.39%-0.04-83.33%0.02-59.09%0.18-27.03%0.27-17.86%0.23-14.29%0.12-62.39%0.44
Diluted earning per share 0.00%0.02-277.78%-0.32-107.41%-0.02-117.39%-0.04-83.33%0.02-59.09%0.18-27.03%0.27-17.86%0.23-14.29%0.12-62.39%0.44
Other composite income
Total composite income 62.12%5.3M-278.07%-54.2M-105.84%-2.63M-115.45%-6.05M-83.96%3.27M-57.62%30.44M-24.74%44.95M-14.18%39.16M-7.56%20.4M-62.19%71.82M
Total composite income of parent company owners 9.22%3.81M-271.71%-54.06M-108.02%-3.69M-115.86%-6.33M-83.22%3.49M-58.44%31.48M-28.10%45.99M-16.62%39.93M-11.07%20.8M-61.63%75.76M
Total composite income of minority owners 779.46%1.49M86.73%-138.76K201.45%1.06M136.72%283.15K45.72%-219.41K73.43%-1.05M75.39%-1.05M65.87%-771.17K69.50%-404.2K47.30%-3.93M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg